HitGen Inc. (SHA:688222)
China flag China · Delayed Price · Currency is CNY
23.90
+0.46 (1.96%)
Last updated: Aug 1, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Deoxyribonucleic Acid Encoded Compound Library Screening Service
97.57M
Log In
Log In
Log In
Log In
Upgrade
Deoxyribonucleic Acid Encoded Compound Library Screening Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Fragment-based Drug Design/Structure-based Drug Design Research & Development Services
90.96M
Log In
Log In
Log In
Log In
Upgrade
Deoxyribonucleic Acid Encoded Compound Library Customization Service
84.69M
Log In
Log In
Log In
Log In
Upgrade
Deoxyribonucleic Acid Encoded Compound Library Customization Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Chemical Synthesis Services
52.00M
Log In
Log In
Log In
Log In
Upgrade
Chemical Synthesis Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Custom Development
19.48M
Log In
Log In
Log In
Log In
Upgrade
Compound Structure Intellectual Property Transfer Fee
10.21M
Log In
Log In
Log In
Log In
Upgrade
New Drug Research Equity Transfer
1.89M
Log In
Log In
Log In
Log In
Upgrade
New Drug Research Equity Transfer Growth
-88.90%
Log In
Log In
Log In
Log In
Upgrade
Other
14.27M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Customized Service
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Customized Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Full-time Equivalent Service
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Full-time Equivalent Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Other
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services - Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
New Drug Research and Development Services
-
Log In
Log In
Log In
Log In
Upgrade
Self Contained Deoxyribonucleic Acid Encoded Compound Library Compound Structure Information and Screening Method
-
Log In
Log In
Log In
Log In
Upgrade
Intellectual Property Transfer Fee For Compound Structure
-
Log In
Log In
Log In
Log In
Upgrade
Intellectual Property Transfer Fee For Compound Structure Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
14.27M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Other
780.75K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-70.11%
Log In
Log In
Log In
Log In
Upgrade
United States
249.87M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
52.21%
Log In
Log In
Log In
Log In
Upgrade
China
62.75M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-8.40%
Log In
Log In
Log In
Log In
Upgrade
Denmark
18.80M
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
-8.13%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
14.57M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
33.50%
Log In
Log In
Log In
Log In
Upgrade
Japan
9.59M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
103.57%
Log In
Log In
Log In
Log In
Upgrade
South Korea
5.09M
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-31.03%
Log In
Log In
Log In
Log In
Upgrade
France
4.62M
Log In
Log In
Log In
Log In
Upgrade
France Growth
-88.72%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
3.76M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
1.29%
Log In
Log In
Log In
Log In
Upgrade
Germany
1.49M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-76.03%
Log In
Log In
Log In
Log In
Upgrade
Other
780.75K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-70.11%
Log In
Log In
Log In
Log In
Upgrade
Switzerland
-
Log In
Log In
Log In
Log In
Upgrade